Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
Maisnar V, Stefanikova Z, Spicka I, Pour L, Minarik J, Flochova E, Radocha J, Gregora E, Stecova N, Jelinek T, Jungova A, Kralikova E, Brozova L, Hajek R. Maisnar V, et al. Among authors: pour l. Neoplasma. 2019 May 23;66(3):499-505. doi: 10.4149/neo_2018_180824N644. Epub 2019 Feb 14. Neoplasma. 2019. PMID: 30784289
Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data.
Campioni M, Agirrezabal I, Hajek R, Minarik J, Pour L, Spicka I, Gonzalez-McQuire S, Jandova P, Maisnar V. Campioni M, et al. Among authors: pour l. Eur J Health Econ. 2020 Mar;21(2):219-233. doi: 10.1007/s10198-019-01122-6. Epub 2019 Oct 31. Eur J Health Econ. 2020. PMID: 31673898 Free PMC article. Clinical Trial.
Multiple myeloma.
Hájek R, Krejcí M, Pour L, Adam Z. Hájek R, et al. Among authors: pour l. Klin Onkol. 2011;24 Suppl:S10-3. Klin Onkol. 2011. PMID: 21923057 Review.
Genomics in multiple myeloma research.
Sevcíková S, Nemec P, Pour L, Hájek R. Sevcíková S, et al. Among authors: pour l. Klin Onkol. 2011;24 Suppl:S34-8. Klin Onkol. 2011. PMID: 21923062
Impact of nestin analysis in multiple myeloma.
Sváchová H, Kovárová L, Stossová J, Potácová A, Pour L, Hájek R. Sváchová H, et al. Among authors: pour l. Klin Onkol. 2011;24 Suppl:S53-7. Klin Onkol. 2011. PMID: 21923066
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).
Hájek R, Masszi T, Petrucci MT, Palumbo A, Rosiñol L, Nagler A, Yong KL, Oriol A, Minarik J, Pour L, Dimopoulos MA, Maisnar V, Rossi D, Kasparu H, Van Droogenbroeck J, Yehuda DB, Hardan I, Jenner M, Calbecka M, Dávid M, de la Rubia J, Drach J, Gasztonyi Z, Górnik S, Leleu X, Munder M, Offidani M, Zojer N, Rajangam K, Chang YL, San-Miguel JF, Ludwig H. Hájek R, et al. Among authors: pour l. Leukemia. 2017 Jan;31(1):107-114. doi: 10.1038/leu.2016.176. Epub 2016 Jun 24. Leukemia. 2017. PMID: 27416912 Free PMC article. Clinical Trial.
277 results